FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2045497611> ?p ?o ?g. }

• W2045497611 endingPage "5" @default.
• W2045497611 startingPage "1" @default.
• W2045497611 abstract "Background . Rapid and early emergence of clinically significant LAM resistance is thought to be unlikely during the first year of treatment, and as a result LAM is thought to be a reasonable choice as a first line agent for prophylaxis during chemotherapy. Aim . To report fatal HBV reactivation despite appropriate LAM prophylaxis in two previously treatment-naive individuals undergoing R-CHOP chemotherapy. Case Presentation . Case 1 is a 65-year-old man with chronic HBV infection: HBeAg-negative, HBV DNA 6.65E5 IU/mL, ALT 43 IU/L, and Fibroscan 4.4 kPa, consistent with F0, who was diagnosed with lymphoma that was treated with R-CHOP and LAM prophylaxis. HBV DNA fell to 2.18E1 IU/mL within 2 months of starting LAM. Four months after chemotherapy, despite ongoing LAM of 7-month duration with confirmed adherence, severe asymptomatic hepatitis was noted during routine monitoring with ALT 1019 IU/L, HBeAg negative, HBV DNA 1.43E7 IU/mL, and genotyping confirmed L80I and M204I mutations. He died 14 days after flare diagnosis despite a switch to tenofovir (HBV DNA had fallen to 1.94E5 IU/mL 2 weeks after starting tenofovir). Case 2 is a 50-year-old man who was found to have HBeAg-negative hepatitis B, ALT 37 IU/L, and no clinical features of cirrhosis (platelets 283, APRI 0.19) after lymphoma diagnosis. Lymphoma was treated with R-CHOP and LAM prophylaxis. Pretreatment HBV DNA was not done but was 8.90E4 IU/mL 3 weeks after starting LAM and 3.96E3 IU/mL 3 months after starting LAM. Two months after chemotherapy, despite ongoing LAM of 7-month duration with confirmed adherence, severe symptomatic hepatitis presenting with jaundice, abdominal pain, and confusion was noted. ALT 902 IU/L, HBeAg negative, HBV DNA 1.02E8 IU/mL, and genotyping confirmed L80I, M80V, and M204V/S mutations. He died 3 days after flare diagnosis despite the addition of tenofovir. Conclusion . Lamivudine should not be used for prophylaxis of patients with chronic hepatitis B with detectable HBV DNA undergoing chemotherapy with rituximab containing cytotoxic chemotherapy even if they have never had exposure to lamivudine in the past. In this setting, lamivudine failure due to resistance can develop quickly leading to liver failure that cannot be salvaged with tenofovir. Whether LAM is safe for prophylaxis with rituximab-based cytotoxic chemotherapy for patients with undetectable HBV DNA is unknown, but agents with a high barrier to resistance may be preferable." @default.
• W2045497611 created "2016-06-24" @default.
• W2045497611 creator A5005263512 @default.
• W2045497611 creator A5020823849 @default.
• W2045497611 creator A5027714342 @default.
• W2045497611 creator A5038453666 @default.
• W2045497611 creator A5049864482 @default.
• W2045497611 date "2013-01-01" @default.
• W2045497611 modified "2023-10-18" @default.
• W2045497611 title "Death from Liver Failure despite Lamivudine Prophylaxis during R-CHOP Chemotherapy due to Rapid Emergence M204 Mutations" @default.
• W2045497611 cites W1579956540 @default.
• W2045497611 cites W1636057362 @default.
• W2045497611 cites W1998968045 @default.
• W2045497611 cites W2021559753 @default.
• W2045497611 cites W2031317669 @default.
• W2045497611 cites W2043533800 @default.
• W2045497611 cites W2052033192 @default.
• W2045497611 cites W2070769352 @default.
• W2045497611 cites W2072571977 @default.
• W2045497611 cites W2101159020 @default.
• W2045497611 cites W2105403730 @default.
• W2045497611 cites W2125474736 @default.
• W2045497611 cites W2126234152 @default.
• W2045497611 cites W2161758234 @default.
• W2045497611 doi "https://doi.org/10.1155/2013/454897" @default.
• W2045497611 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4208428" @default.
• W2045497611 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25374716" @default.
• W2045497611 hasPublicationYear "2013" @default.
• W2045497611 type Work @default.
• W2045497611 sameAs 2045497611 @default.
• W2045497611 citedByCount "9" @default.
• W2045497611 countsByYear W20454976112013 @default.
• W2045497611 countsByYear W20454976112015 @default.
• W2045497611 countsByYear W20454976112016 @default.
• W2045497611 countsByYear W20454976112017 @default.
• W2045497611 countsByYear W20454976112018 @default.
• W2045497611 countsByYear W20454976112019 @default.
• W2045497611 countsByYear W20454976112020 @default.
• W2045497611 crossrefType "journal-article" @default.
• W2045497611 hasAuthorship W2045497611A5005263512 @default.
• W2045497611 hasAuthorship W2045497611A5020823849 @default.
• W2045497611 hasAuthorship W2045497611A5027714342 @default.
• W2045497611 hasAuthorship W2045497611A5038453666 @default.
• W2045497611 hasAuthorship W2045497611A5049864482 @default.
• W2045497611 hasBestOaLocation W20454976111 @default.
• W2045497611 hasConcept C126322002 @default.
• W2045497611 hasConcept C141071460 @default.
• W2045497611 hasConcept C203014093 @default.
• W2045497611 hasConcept C2522874641 @default.
• W2045497611 hasConcept C2775940106 @default.
• W2045497611 hasConcept C2776694085 @default.
• W2045497611 hasConcept C2777214474 @default.
• W2045497611 hasConcept C2777382497 @default.
• W2045497611 hasConcept C2777410769 @default.
• W2045497611 hasConcept C2777869810 @default.
• W2045497611 hasConcept C2777910003 @default.
• W2045497611 hasConcept C2779338263 @default.
• W2045497611 hasConcept C2779725641 @default.
• W2045497611 hasConcept C2780593183 @default.
• W2045497611 hasConcept C71924100 @default.
• W2045497611 hasConcept C90924648 @default.
• W2045497611 hasConceptScore W2045497611C126322002 @default.
• W2045497611 hasConceptScore W2045497611C141071460 @default.
• W2045497611 hasConceptScore W2045497611C203014093 @default.
• W2045497611 hasConceptScore W2045497611C2522874641 @default.
• W2045497611 hasConceptScore W2045497611C2775940106 @default.
• W2045497611 hasConceptScore W2045497611C2776694085 @default.
• W2045497611 hasConceptScore W2045497611C2777214474 @default.
• W2045497611 hasConceptScore W2045497611C2777382497 @default.
• W2045497611 hasConceptScore W2045497611C2777410769 @default.
• W2045497611 hasConceptScore W2045497611C2777869810 @default.
• W2045497611 hasConceptScore W2045497611C2777910003 @default.
• W2045497611 hasConceptScore W2045497611C2779338263 @default.
• W2045497611 hasConceptScore W2045497611C2779725641 @default.
• W2045497611 hasConceptScore W2045497611C2780593183 @default.
• W2045497611 hasConceptScore W2045497611C71924100 @default.
• W2045497611 hasConceptScore W2045497611C90924648 @default.
• W2045497611 hasLocation W20454976111 @default.
• W2045497611 hasLocation W20454976112 @default.
• W2045497611 hasLocation W20454976113 @default.
• W2045497611 hasLocation W20454976114 @default.
• W2045497611 hasLocation W20454976115 @default.
• W2045497611 hasLocation W20454976116 @default.
• W2045497611 hasOpenAccess W2045497611 @default.
• W2045497611 hasPrimaryLocation W20454976111 @default.
• W2045497611 hasRelatedWork W1556816728 @default.
• W2045497611 hasRelatedWork W2010301081 @default.
• W2045497611 hasRelatedWork W2142153682 @default.
• W2045497611 hasRelatedWork W2164269826 @default.
• W2045497611 hasRelatedWork W2367929075 @default.
• W2045497611 hasRelatedWork W2382375426 @default.
• W2045497611 hasRelatedWork W2392939228 @default.
• W2045497611 hasRelatedWork W2771386081 @default.
• W2045497611 hasRelatedWork W3031056812 @default.
• W2045497611 hasRelatedWork W4386172594 @default.
• W2045497611 hasVolume "2013" @default.
• W2045497611 isParatext "false" @default.
• W2045497611 isRetracted "false" @default.

• next